# Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan

Study · id `cardio:ct-nct02941367` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02941367](<https://clinicaltrials.gov/study/NCT02941367>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02941367

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.

## Technical summary

Registry record NCT02941367. Randomized; no masking; primary purpose treatment. Start 2017-02-23 (actual); primary completion 2017-08-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 184 participants (enrolled count; ClinicalTrials.gov record NCT02941367, source copy `cardio:ctgov-nct02941367-2022-04-25`, retrieved 2026-10-26)
- Started: 2017-02-23 (actual) (ClinicalTrials.gov record NCT02941367, source copy `cardio:ctgov-nct02941367-2022-04-25`, retrieved 2026-10-26)
- Primary completion: 2017-08-04 (actual) (ClinicalTrials.gov record NCT02941367, source copy `cardio:ctgov-nct02941367-2022-04-25`, retrieved 2026-10-26)
- Completion: 2017-08-04 (actual) (ClinicalTrials.gov record NCT02941367, source copy `cardio:ctgov-nct02941367-2022-04-25`, retrieved 2026-10-26)
- Countries: India; Israel; Kuwait; Türkiye (ClinicalTrials.gov record NCT02941367, source copy `cardio:ctgov-nct02941367-2022-04-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02941367-2022-04-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
- Acronym: LixiRam
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Lixisenatide (AVE0010)
- Intervention (Drug): Sulfonylurea
- Intervention (Drug): metformin
- Intervention (Drug): basal insulin
- Lead sponsor: Sanofi
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Sanofi (`cardio:org-sanofi`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trial (`cardio:pubmed-32302665`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: aaf98583b9bcf4f73af4cc37798f33c0526fb61dc79279178d9177d2bca4a82d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
